The Eizo RadiForce RX560 is the first medical monitor to employ low-temperature polysilicon (LTPS) liquid crystal display technology, allowing it to achieve high brightness levels typically reserved for monochrome monitors. This innovation enables the RX560 to display high-definition monochrome breast tomosynthesis and mammography images, as well as color images such as ultrasound and pathology. Eizo Radiforce RX560 boasts a high contrast ratio of 1500:1, comparable to that of monochrome monitors, delivering deep blacks without washout.
FDA Approved for Breast Tomosynthesis and Mammography
The Eizo Radiforce RX560 diagnostic monitor has successfully secured FDA 510(k) clearance from the U.S. Food and Drug Administration, specifically for breast tomosynthesis and mammography applications. This approval highlights the monitor's exceptional capabilities in delivering high-quality, detailed breast screening images, a critical factor for radiologists seeking top-tier performance in their diagnostic tools.
